The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase II trial report of the new preoperative chemotherapy with S-1 and docetaxel for advanced breast cancer.
M. Nakagawa
No relevant relationships to disclose
M. Aoyama
No relevant relationships to disclose
M. Ikeda
No relevant relationships to disclose
M. Morimoto
No relevant relationships to disclose
H. Takechi
No relevant relationships to disclose
Y. Kawakami
No relevant relationships to disclose
K. Kennzaki
No relevant relationships to disclose
A. Tangoku
No relevant relationships to disclose